Cargando…
Rational Design of a Peptidomimetic Inhibitor of Gelsolin Amyloid Aggregation
Gelsolin amyloidosis (AGel) is characterized by multiple systemic and ophthalmic features resulting from pathological tissue deposition of the gelsolin (GSN) protein. To date, no cure is available for the treatment of any form of AGel. More than ten single-point substitutions in the GSN gene are res...
Autores principales: | Bollati, Michela, Peqini, Kaliroi, Barone, Luigi, Natale, Carmina, Beeg, Marten, Gobbi, Marco, Diomede, Luisa, Trucchi, Michelangelo, de Rosa, Matteo, Pellegrino, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698219/ https://www.ncbi.nlm.nih.gov/pubmed/36430461 http://dx.doi.org/10.3390/ijms232213973 |
Ejemplares similares
-
A novel hotspot of gelsolin instability triggers an alternative mechanism of amyloid aggregation
por: Bollati, Michela, et al.
Publicado: (2021) -
Nonphosphorylated tau slows down Aβ(1–42) aggregation, binds to Aβ(1–42) oligomers, and reduces Aβ(1–42) toxicity
por: Beeg, Marten, et al.
Publicado: (2021) -
Amyloid-β-Derived Peptidomimetics Inhibits Tau
Aggregation
por: Gorantla, Nalini V., et al.
Publicado: (2021) -
Can Antiviral Activity of Licorice Help Fight COVID-19 Infection?
por: Diomede, Luisa, et al.
Publicado: (2021) -
Multi-eGO: An in silico lens to look into protein aggregation kinetics at atomic resolution
por: Scalone, Emanuele, et al.
Publicado: (2022)